These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30994574)

  • 1. Partner status moderates the relationships between sexual problems and self-efficacy for managing sexual problems and psychosocial quality-of-life for postmenopausal breast cancer survivors taking adjuvant endocrine therapy.
    Dorfman CS; Arthur SS; Kimmick GG; Westbrook KW; Marcom PK; Corbett C; Edmond SN; Shelby RA
    Menopause; 2019 Aug; 26(8):823-832. PubMed ID: 30994574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
    Frechette D; Paquet L; Verma S; Clemons M; Wheatley-Price P; Gertler SZ; Song X; Graham N; Dent S
    Breast Cancer Res Treat; 2013 Aug; 141(1):111-7. PubMed ID: 23942873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy.
    Shelby RA; Edmond SN; Wren AA; Keefe FJ; Peppercorn JM; Marcom PK; Blackwell KL; Kimmick GG
    Support Care Cancer; 2014 Oct; 22(10):2851-9. PubMed ID: 24821365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners.
    Hummel SB; Hahn DEE; van Lankveld JJDM; Oldenburg HSA; Broomans E; Aaronson NK
    J Sex Med; 2017 Oct; 14(10):1248-1259. PubMed ID: 28923310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.
    Baumgart J; Nilsson K; Evers AS; Kallak TK; Poromaa IS
    Menopause; 2013 Feb; 20(2):162-8. PubMed ID: 22990756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
    Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
    Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study.
    Bryl K; Chimonas S; Li X; Li SQ; Mao JJ
    Breast Cancer Res Treat; 2023 Jul; 200(2):257-264. PubMed ID: 37226019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual inactivity in partnered female cancer survivors.
    Marino JL; Saunders CM; Hickey M
    Maturitas; 2017 Nov; 105():89-94. PubMed ID: 28528727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity, health-related quality of life, and adjuvant endocrine therapy-related symptoms in women with hormone receptor-positive breast cancer.
    Sheppard VB; Dash C; Nomura S; Sutton AL; Franco RL; Lucas A; Ross M; Adams-Campbell L
    Cancer; 2020 Sep; 126(17):4059-4066. PubMed ID: 32614992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.
    Schover LR; Baum GP; Fuson LA; Brewster A; Melhem-Bertrandt A
    J Sex Med; 2014 Dec; 11(12):3102-11. PubMed ID: 25141792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation.
    Gomaa S; Lopez A; Slamon R; Smith R; Lapitan E; Nightingale G; Miller SM; Wen KY
    Support Care Cancer; 2023 Nov; 31(12):719. PubMed ID: 38008817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in Malaysia.
    Choo SB; Saifulbahri A; Zullkifli SN; Fadzil ML; Redzuan AM; Abdullah N; Bustamam RSA; Ahmad HZ; Shah NM
    Climacteric; 2019 Apr; 22(2):175-181. PubMed ID: 30556740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual function after breast cancer.
    Panjari M; Bell RJ; Davis SR
    J Sex Med; 2011 Jan; 8(1):294-302. PubMed ID: 21199377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Symptom Distress: Key Factors for Patients on Adjuvant Endocrine Therapy for Breast Cancer.
    Post KE; Ahmad Z; Jankauskaite G; Centracchio J; Oswald L; Horick N; Park ER; Temel JS; Greer JA; Jacobs J
    J Pain Symptom Manage; 2024 Jan; 67(1):88-97. PubMed ID: 37816436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
    Kimmick G; Edmond SN; Bosworth HB; Peppercorn J; Marcom PK; Blackwell K; Keefe FJ; Shelby RA
    Breast; 2015 Oct; 24(5):630-6. PubMed ID: 26189978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
    Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
    BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET).
    Shelby RA; Dorfman CS; Bosworth HB; Keefe F; Sutton L; Owen L; Corsino L; Erkanli A; Reed SD; Arthur SS; Somers T; Barrett N; Huettel S; Gonzalez JM; Kimmick G
    Contemp Clin Trials; 2019 Jan; 76():120-131. PubMed ID: 30472215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of endocrine treatments for breast cancer on health-related quality of life.
    Buijs C; de Vries EG; Mourits MJ; Willemse PH
    Cancer Treat Rev; 2008 Nov; 34(7):640-55. PubMed ID: 18514425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The experiences of adjuvant endocrine therapy for women breast cancer survivors: A literature review.
    Long Y; Xie S; Liu Q; Xu F; Li Q; Wang N; Zhang Y
    Medicine (Baltimore); 2023 Dec; 102(51):e36704. PubMed ID: 38134074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
    Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
    Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.